PupillOmetry for Prediction of DelirIUM

Delirium Clinical Trial

— PODIUM  

Official title:

Automated Pupillometry and Delirium in Patients on Mechanical Ventilation in Intensive Care-intensive Care

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05248035
• Other study ID #: APHP201165
• Secondary ID: 2020-A03517-32
• Status: Recruiting
• Start date: April 15, 2022
• Est. completion date: June 2025

Study information

• Verified date: March 2024
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Pierre Jaquet, MD
• Phone: 0676653840
• Email: pierre.jaquet[@]ch-stdenis.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Delirium in intensive care unit (ICU) is a serious event. It is associated with short-term complications (agitation, self-extubation, accidental removal of catheters, prolonged length of stay and ventilation), excess mortality, functional and cognitive impairment. It is particularly frequent in patients requiring mechanical ventilation but diagnosis is not easy. There are screening scales, but it is insufficiently used in clinical practice: Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Intensive Care Delirium Screening Checklist (ICDSC). These scales are time consuming and require trained personnel. Automated pupillometry (AP) is a new device to objectively, rapidly, and reproducibly identify acute brain dysfunction. Recent data suggest that AP could be used to predict delirium in the ICU. This would need to be validated for routine use in the ICU.

Evaluate AP parameters on day 3 of invasive mechanical ventilation as a predictive tool for CAM-ICU diagnosed delirium during the first 14 days of ICU stay.

Study design: Prospective, multicenter, non-interventional cohort

Measurement of the AP parameters at day 3 after ICU admission and their predictive performance for delirium: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses.

Description:

Automated pupillometry is an easy-to-use device that allows for accurate objective assessment of the photomotor reflex.

AP it allows the acquisition of dynamic parameters in addition to pupillary diameter, such as quantitative measurement of pupillary reactivity, speed, or latency of pupil contraction after a standardized light stimulus.

Automated pupillometry has been evaluated in ICU, in a monocentric study in non-brain-damaged patients, AP was used for the first time to predict the occurrence of delirium. Interestingly, the decrease in pupillary diameter variation at day 0 after 48h of IMV (D0) was independently associated with the occurrence of delirium during the ICU stay. This seems promising but requires a validation study in order to recommend its routine use.

The hypothesis is the AP parameters predict the risk of delirium in ICU-patients ventilated for more than 48 hours. Specifically, AP parameters on the D3 of mechanical ventilation allow predicting the occurrence of delirium during the first 14 days of resuscitation. This will allow early change of patient management, by identifying patients at risk of delirium and serious short-term adverse events.

This is a prospective, observational, multicenter cohort study involving 5 ICU in the Paris area.

To ensure the 213 planned inclusions and the 3-month follow-up of all included patients, a research duration of 15 months is expected. The ethical committee of the French Society of intensive care medicine (FICS) approved the study protocol (CE SRLF 20-09) and required Family members' informed consent.

At D0, patient is included and we start to evaluate AP parameter twice a day from D0 to D7 and to monitor delirium occurrence using Confusion assessment monitoring in the ICU (CAM ICU).

We assess changes in AP parameters from D0 to D7 of mechanical ventilation in patients with and without CAM-ICU diagnosed delirium during the first 14 days of ICU stay.

Automated pupillometry protocol : The AP is measured for each eye from D0 onwards, twice a day, as long as the patient is under mechanical ventilation and up to a maximum of 7 days (D7), using the NPI Neuroptics® device. These parameters were measured by the nurses or by the investigating physician not involved in the patient's care. At each measurement point, the mean value of both eyes was used for the analyses. The AP parameters are: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses. Routine neurological monitoring in ICU includes the RASS score every 4 hours. If the RASS score is ≥ -3 then CAM-ICU will be administered twice daily starting on day 3 by the patient's attending physicians. The physicians in charge of the patient will be blinded to the AP results.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 213
• Est. completion date: June 2025
• Est. primary completion date: December 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria :

• Adults = 18 years

• mechanical ventilation since 48h

• Information and no opposition of patient or close person if he is present at the time of inclusion, otherwise urgent inclusion

Exclusion criteria :

• Patient diagnosed confused by CAM-ICU on D0

• Ophthalmological pathology modifying the photomotor reflex

• Acute or chronic neurological pathology: Cerebro-injured patients (head trauma, stroke, cardiopulmonary arrest, hypoglycemic coma, meningitis / encephalitis / brain abscess), dementia with MMSE <24

• Duration of stay in intensive care> 72h or duration of ventilation> 72h

• Readmission in intensive care

• Moribund patient

• Patient under guardianship or curatorship

• No affiliation to social security (beneficiary or assignee)

Related Conditions & MeSH terms

• Delirium
• ICU

Intervention

Other:
• Adult patient hospitalized in ICU
acquisition of dynamic parameters in addition to pupillary diameter, such as . pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses after a standardized light stimulus

Locations

Country	Name	City	State
France	Hôpital Bichat-Claude Bernard	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of the parameters of the automated pupillometry		at day 0
Secondary	Measurement of the parameters of the automated pupillometry		until 7 days
Secondary	Rate of agitated patients (agitation is defined by a Richmond Agitation-Sedation Scale > +1(RASS score: +4; -5 with 0= better outcome) requiring use of neuroleptics or dexmedetomidine)		until day14 of resuscitation or discharge from resuscitation
Secondary	Self-extubation rate		until day14 or stop invasive ventilation
Secondary	Accidental catheter ablation rate		up to day14 resuscitation or resuscitation discharge
Secondary	Number of days of mechanical ventilation		until D14 or stopping invasive ventilation
Secondary	Number of days in intensive care		until day90
Secondary	Death rate		at day90
Secondary	Early PREdiction of DELIRium in ICu patients (E-PRE-DELIRIC) score		at day 0
Secondary	Measurement of the parameters of the automated pupillometry in the subgroup of patients hospitalized for sepsis		day0
Secondary	Measurement of the parameters of the automated pupillometry in the subgroup of patients hospitalized for cardiogenic shock under veno-arterial circulatory support		day0